Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b4f16ad70ddfeb0b838c113aaae408a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
filingDate |
2007-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc03d5abe948ae29a8c1bfb6bc828ee1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5040363bf76abada024062d25cec407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ae9bdc26c4c4eb5ded5a81efb3652bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a58041c1d4c84469304b71946babb50 |
publicationDate |
2008-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7435826-B2 |
titleOfInvention |
Substituted sulfoxides |
abstract |
The present invention relates to a process for preparing substituted sulfoxides either as a single enantiomer or in an enantiomerically enriched form. Thus, racemic omeprazole is reacted with (S)-camphorsulfonyl chloride to form a diastereomeric mixture and the diastereomers are separated by fractional crystallization, followed by deprotection to give esomeprazole. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008076930-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8173817-B2 |
priorityDate |
2004-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |